95 related articles for article (PubMed ID: 22716258)
1. Intratumoral mast cell number is negatively correlated with tumor size and mitosis in dermatofibrosarcoma protuberans.
Kim M; Cho KH; Lee JH; Chang MS; Cho S
Exp Dermatol; 2012 Jul; 21(7):559-61. PubMed ID: 22716258
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
3. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
4. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
Arican O; Bakaris S; Bulbuloglu E; Ezberci F
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
[TBL] [Abstract][Full Text] [Related]
5. Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?
Sellheyer K; Nelson P; Krahl D
Br J Dermatol; 2009 Dec; 161(6):1317-22. PubMed ID: 19659472
[TBL] [Abstract][Full Text] [Related]
6. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
7. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
[TBL] [Abstract][Full Text] [Related]
8. Fibrosarcomatous dermatofibrosarcoma protuberans with myofibroblastic differentiaion: a histologically distinctive variant [corrected].
O'Connell JX; Trotter MJ
Mod Pathol; 1996 Mar; 9(3):273-8. PubMed ID: 8685227
[TBL] [Abstract][Full Text] [Related]
9. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.
Sasaki M; Ishida T; Horiuchi H; MacHinami R
Pathol Int; 1999 Sep; 49(9):799-806. PubMed ID: 10504551
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
12. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
[TBL] [Abstract][Full Text] [Related]
13. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
Quigley EA; Marghoob AA; Busam KJ; Chen CS
Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
[No Abstract] [Full Text] [Related]
14. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
Reimann JD; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans is CD117 negative even after extreme antigen retrieval conditions.
Fernandez-Flores A
Rom J Morphol Embryol; 2007; 48(4):419-21. PubMed ID: 18060194
[TBL] [Abstract][Full Text] [Related]
16. [Fibrosarcomatous variant of dermatofibrosarcoma protuberans: clinicopathologic analysis of 4 cases].
Diedhiou A; Larsimont D; Vandeweyer E; Andry G; De Saint-Aubain Somerhausen N
Ann Pathol; 2001 Apr; 21(2):164-7. PubMed ID: 11373589
[TBL] [Abstract][Full Text] [Related]
17. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
18. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
19. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement.
Bague S; Folpe AL
Am J Dermatopathol; 2008 Aug; 30(4):327-32. PubMed ID: 18645303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]